SAB Biotherapeutics, Inc. (SABS) quarterly income statement — complete revenue, gross profit & net income history
SAB Biotherapeutics, Inc. (SABS) annual income statement — 7-year revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 114.7K | 0 | 263.14K | 944.58K | 305.01K | 1.27M | 85.52K | 581.1K | 2.16M | 3.59M | 6.35M | 11.8M | 11.06M |
| Revenue Growth % | - | - | - | -100% | - | -100% | -100% | -62.4% | -100% | 207.7% | 62.55% | -85.88% | -64.7% | -98.65% | -95.08% | -80.46% | -75.55% | -65.13% | -30.27% | - |
| Cost of Goods Sold | 0 | 0 | 752.67K | 763.3K | 765.47K | 822K | 7.66M | 785.71K | 966.86K | 1.02M | 1.98M | 944.4K | 985.45K | 892.27K | 923.17K | 923.52K | 909.91K | 8.58M | 0 | 10.65M |
| COGS % of Revenue | - | - | - | - | - | - | - | 685.03% | - | 388.39% | 210.12% | 309.63% | 77.78% | 1043.37% | 158.87% | 42.74% | 25.35% | 135.18% | - | 96.29% |
| Gross Profit | 0 | 0 | -752.67K | -763.3K | -765.47K | -822K | -7.66M | -671.01K | -966.86K | -758.86K | -1.04M | -639K | 281.92K | -806.75K | -342.07K | 1.24M | 2.68M | -2.23M | 11.8M | 410.33K |
| Gross Margin % | - | - | - | - | - | - | - | -585.03% | - | -288.39% | -110.12% | -209.5% | 22.25% | -943.37% | -58.87% | 57.26% | 74.65% | -35.18% | 100% | 3.71% |
| Gross Profit Growth % | 100% | 100% | 90.17% | -13.75% | 20.83% | -8.32% | -636.16% | -5.01% | -442.96% | 5.94% | -204.08% | -151.64% | -89.48% | 63.89% | -102.9% | 201.55% | -81.22% | -371.39% | 184.7% | - |
| Operating Expenses | 25.9M | 23.38M | 19.25M | 15.01M | 11.91M | 8.91M | 3.11M | 9.34M | 10.34M | 9.44M | 10.35M | 18.23M | 5.6M | 5.67M | 7.06M | 9.1M | 10.49M | 4.31M | 18.51M | 7.75M |
| OpEx % of Revenue | - | - | - | - | - | - | - | 8141.23% | - | 3588.56% | 1095.78% | 5978.27% | 442.37% | 6630.03% | 1214.92% | 421% | 292.14% | 67.85% | 156.83% | 70.12% |
| Selling, General & Admin | 7.82M | 7.21M | 5.87M | 5.04M | 3.71M | 2.74M | 3.11M | 1.71M | 2.51M | 2.64M | 2.23M | 14.88M | 2.57M | 2.03M | 2.55M | 1.96M | 3.16M | 4.31M | 5.19M | 7.75M |
| SG&A % of Revenue | - | - | - | - | - | - | - | 1489.01% | - | 1004.28% | 235.67% | 4878.84% | 202.92% | 2375.21% | 438.64% | 90.67% | 88% | 67.85% | 43.94% | 70.12% |
| Research & Development | 18.08M | 16.17M | 13.38M | 10.73M | 8.95M | 7M | 7.66M | 7.63M | 7.83M | 6.8M | 8.12M | 4.3M | 4.02M | 3.64M | 4.51M | 7.14M | 7.33M | 8.58M | 13.32M | 10.65M |
| R&D % of Revenue | - | - | - | - | - | - | - | 6652.22% | - | 2584.28% | 860.11% | 1408.8% | 317.28% | 4254.82% | 776.29% | 330.33% | 204.15% | 135.18% | 112.89% | 96.29% |
| Other Operating Expenses | 0 | 0 | 0 | -763.3K | -743.76K | -822K | -1000K | 0 | 0 | 0 | 0 | -943.62K | -986.16K | 0 | 0 | 0 | 0 | -1000K | 0 | -1000K |
| Operating Income | -25.9M | -23.38M | -20M | -15.77M | -12.68M | -9.73M | -10.77M | -10.01M | -11.31M | -10.2M | -11.39M | -18.87M | -5.32M | -6.48M | -7.4M | -7.86M | -7.81M | -6.54M | -6.71M | -7.34M |
| Operating Margin % | - | - | - | - | - | - | - | -8726.26% | - | -3876.95% | -1205.9% | -6187.97% | -420.13% | -7573.4% | -1273.79% | -363.74% | -217.49% | -103.03% | -56.83% | -66.41% |
| Operating Income Growth % | -104.27% | -140.21% | -85.64% | -57.56% | -12.11% | 4.6% | 5.43% | 46.97% | -112.46% | -57.52% | -53.89% | -140.13% | 31.82% | 1.01% | -10.36% | -7.02% | -95.65% | -127.78% | -924.07% | - |
| EBITDA | -25.08M | -22.54M | -19.25M | -15.01M | -11.91M | -8.96M | -9.99M | -9.22M | -10.34M | -9.18M | -9.41M | -17.93M | -4.34M | -5.58M | -6.48M | -6.94M | -6.9M | -5.79M | -6.03M | -6.72M |
| EBITDA Margin % | - | - | - | - | - | - | - | -8041.23% | - | -3488.56% | -995.78% | -5878.35% | -342.35% | -6530.03% | -1114.92% | -321% | -192.14% | -91.23% | -51.09% | -60.81% |
| EBITDA Growth % | -110.48% | -151.64% | -92.57% | -62.71% | -15.19% | 2.41% | -6.25% | 48.56% | -138.44% | -64.38% | -45.18% | -158.48% | 37.11% | 3.61% | -7.45% | -3.16% | -92.68% | -121.67% | -674.34% | - |
| D&A (Non-Cash Add-back) | 823K | 834.33K | 752.67K | 763.3K | 765.47K | 773.7K | 778.3K | 785.71K | 966.86K | 1.02M | 1.98M | 944.4K | 985.45K | 892.27K | 923.17K | 923.52K | 909.91K | 749.19K | 677.44K | 619.98K |
| EBIT | -25.9M | -22.43M | -18.81M | -16.8M | 45.49M | -10.05M | -5.13M | -11.32M | -10.27M | -7.24M | -4.95M | -22.78M | -5.03M | -6.81M | -7.26M | -7.76M | -7.01M | -6.54M | 1.15M | -7.34M |
| Net Interest Income | 1.61M | 1.65M | 984.45K | 637.28K | 611.94K | -50.78K | -7.07K | 65.5K | 199.14K | 281.44K | 421.52K | 406.17K | -55.34K | -46.75K | -34.4K | -57.77K | -53.24K | -55.41K | -64.09K | -280K |
| Interest Income | 1.61M | 1.71M | 1.05M | 700.74K | 655.23K | 13.56K | 62.5K | 136.37K | 277.17K | 374.56K | 497.89K | 484.05K | 14.36K | 28.57K | 57.99K | 29.93K | 17.39K | 15.82K | 7.93K | 14.87K |
| Interest Expense | 0 | 62K | 62.74K | 63.46K | 43.29K | 64.34K | 69.56K | 70.88K | 78.04K | 93.12K | 76.37K | 77.88K | 69.7K | 75.32K | 92.39K | 87.7K | 70.63K | 71.24K | 72.02K | 294.46K |
| Other Income/Expense | 3.6M | 886K | 1.13M | -1.09M | 58.12M | -382.21K | 5.58M | -1.39M | 959.96K | 2.87M | 6.36M | -3.98M | 220.6K | -404.27K | 48.19K | 11.04K | 731.25K | 1.67M | 7.79M | -4.21M |
| Pretax Income | -22.3M | -22.49M | -18.87M | -16.86M | 45.45M | -10.11M | -5.2M | -11.39M | -10.35M | -7.34M | -5.03M | -22.86M | -5.1M | -6.88M | -7.35M | -7.85M | -7.08M | -4.87M | 1.08M | -11.55M |
| Pretax Margin % | - | - | - | - | - | - | - | -9934.52% | - | -2787.69% | -532.06% | -7493.83% | -402.68% | -8046.13% | -1265.5% | -363.23% | -197.12% | -76.66% | 9.13% | -104.46% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.63K | 0 | -92.28K | 92.28K | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -0.33% | 0% | 1.9% | 8.56% | 0% |
| Net Income | -22.3M | -22.49M | -18.87M | -16.86M | 45.45M | -10.11M | -5.2M | -11.39M | -10.35M | -7.34M | -5.03M | -22.86M | -5.1M | -6.88M | -7.35M | -7.87M | -7.08M | -4.78M | 985.86K | -11.55M |
| Net Margin % | - | - | - | - | - | - | - | -9934.52% | - | -2787.69% | -532.06% | -7493.83% | -402.68% | -8046.13% | -1265.5% | -364.42% | -197.12% | -75.21% | 8.35% | -104.46% |
| Net Income Growth % | -149.07% | -122.37% | -263.09% | -47.97% | 539.11% | -37.88% | -3.4% | 50.15% | -102.85% | -6.61% | 31.66% | -190.26% | 27.9% | -44.07% | -845.93% | 31.83% | -74.24% | -62.36% | -30.07% | - |
| Net Income (Continuing) | -22.3M | -22.49M | -18.87M | -16.86M | 45.45M | -10.11M | -5.2M | -11.39M | -10.35M | -7.34M | -5.03M | -22.86M | -5.1M | -6.88M | -7.35M | -7.87M | -7.08M | -4.78M | 985.86K | -11.55M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.24 | -0.28 | -0.35 | -0.81 | 0.58 | -1.09 | -0.56 | -1.23 | -1.12 | -0.79 | -0.54 | -3.86 | -0.97 | -1.36 | -1.46 | -1.56 | -1.60 | -1.11 | 0.22 | -4.11 |
| EPS Growth % | -141.38% | 74.31% | 37.5% | 34.15% | 151.79% | -37.97% | -3.7% | 68.13% | -15.46% | 41.91% | 63.01% | -147.44% | 39.38% | -22.52% | -763.64% | 62.04% | -2033.33% | -63.24% | -31.25% | - |
| EPS (Basic) | -0.24 | -0.28 | -0.35 | -0.06 | 4.26 | -1.09 | -0.56 | -1.23 | -1.12 | -0.79 | -0.54 | -3.86 | -0.97 | -1.36 | -1.46 | -1.56 | -1.60 | -1.11 | 0.23 | -4.11 |
| Diluted Shares Outstanding | 93.24M | 79.75M | 53.56M | 47.61M | 77.86M | 9.29M | 9.29M | 9.26M | 9.26M | 9.26M | 9.24M | 5.93M | 5.24M | 5.04M | 5.04M | 5.04M | 4.3M | 4.3M | 4.58M | 4.35M |
| Basic Shares Outstanding | 93.24M | 79.75M | 53.56M | 47.61M | 10.66M | 9.29M | 9.29M | 9.26M | 9.26M | 9.26M | 9.24M | 5.93M | 5.24M | 5.04M | 5.04M | 5.04M | 4.3M | 4.3M | 4.31M | 4.35M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |